lixiana

LIXIANA ® is a once-daily, oral direct factor Xa inhibitor for prevention and treatment of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) or venous thromboembolism (VTE). tinggi net bola voli untuk putr It has a consistent efficacy and safety profile, a superior reduction in major bleeding vs warfarin, and a practical guide for healthcare professionals